Skip to content
[P]pubcas
Independent chemical reference Compare
Chemical substance record

Rosoxacin

40034-42-2C17H14N2O3294.31 g/mol

A quinolinemonocarboxylic acid that is 1,4-dihydroquinoline-3-carboxylic acid that is substituted by an ethyl group at position 1 and by a pyridin-4-yl group at position 7. An antibacterial drug, active against Neisseria gonorrhoeae, it has been used for treating urinary tract infections and certain sexually transmitted diseases. — ChEBI

Safety references

Safety documents & references

Supplier matching matters

Find the safety document for your specific supplier, product number and grade.

Find a product-specific SDS

Safety guides and government classification records are not a manufacturer’s SDS. Match supplier, product number, concentration, physical form, region and revision before using a document.

Identity & molecular properties

Source-linked values
CAS number40034-42-2ChEBI ↗
Molecular formulaC17H14N2O3ChEBI ↗
Molar mass294.31 g/molChEBI ↗
Monoisotopic mass294.10044 DaChEBI ↗
Formal charge0ChEBI ↗
ChEBI identifierCHEBI:131715ChEBI ↗

Cross-source molecular data

PubChem
Molar mass294.30 g/molPubChem ↗
Exact mass294.10044231 DaPubChem ↗
Computed XLogP0.6PubChem ↗
Topological polar surface area (Ų)70.5PubChem ↗
H-bond donors1PubChem ↗
H-bond acceptors5PubChem ↗
Rotatable bonds3PubChem ↗

PubChem computed values are shown separately from the ChEBI record. An exact InChIKey match was used to connect the records. Molecular descriptors do not describe a supplied product’s purity, particle size or performance.

Names & structural identifiers

Copy any identifier
rosoxacin
1-ethyl-4-oxo-7-(pyridin-4-yl)-1,4-dihydroquinoline-3-carboxylic acid
XBPZXDSZHPDXQU-UHFFFAOYSA-N
CCn1cc(C(=O)O)c(=O)c2ccc(-c3ccncc3)cc21
InChI=1S/C17H14N2O3/c1-2-19-10-14(17(21)22)16(20)13-4-3-12(9-15(13)19)11-5-7-18-8-6-11/h3-10H,2H2,1H3,(H,21,22)

Names & synonyms

1-ethyl-4-oxo-7-(pyridin-4-yl)-1,4-dihydroquinoline-3-carboxylic acidEradacilrosoxacinarosoxacinerosoxacinum

Names are supplied by ChEBI. Trade names and related synonyms may describe a broader product context.

Classification & relationships

ChEBI ontology

Roles recorded in ChEBI

antibacterial agentantiinfective agentantibacterial drug

Database role annotations describe reported biological or chemical roles; they are not product approvals or recommendations for use.

Mass ↔ amount of substance

Calculated from sourced mass
Equivalent amount
0.00339778 mol

Uses 294.31 g/mol from ChEBI. Assumes the substance described by this record; no purity or concentration correction is applied.

Elemental composition

Theoretical mass fractions
C
Carbon · 17 atoms
69.38%
O
Oxygen · 3 atoms
16.31%
N
Nitrogen · 2 atoms
9.52%
H
Hydrogen · 14 atoms
4.79%

Calculated theoretical mass fractions from the reported formula and PubChem periodic-table atomic masses. These are not assay or purity results.

Research & patent references

Selected source associations
A selective spectrophotometric method for determination of rosoxacin antibiotic using sodium nitroprusside as a chromogenic reagent. ↗Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy · 2008 Apr · PMID 17804284
Rosoxacin in the treatment of uncomplicated acute gonococcal urethritis. ↗Journal of postgraduate medicine · 1990 Oct · PMID 1966732
DE2224090 · Patent reference ↗Patent cross-reference supplied by ChEBI. Association alone does not establish claim scope.
US3753993 · Patent reference ↗Patent cross-reference supplied by ChEBI. Association alone does not establish claim scope.
US3907808 · Patent reference ↗Patent cross-reference supplied by ChEBI. Association alone does not establish claim scope.

Sources & record history

Checked 27 Sep 2026
EMBL-EBI ChEBI · CHEBI:131715

Release 255, 9 September 2026. ChEBI three-star (manually annotated) source entry. View original record ↗ · CC BY 4.0

NCBI PubChem · CID 287180 · retrieved 2026-09-27

PubCAS formats source data, connects references and computes explicitly labelled conversions. CAS cross-references are supplied by ChEBI; they do not constitute CAS verification or endorsement.